M
Mehdi Yaseri
Researcher at Tehran University of Medical Sciences
Publications - 435
Citations - 35439
Mehdi Yaseri is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 35, co-authored 382 publications receiving 25507 citations. Previous affiliations of Mehdi Yaseri include Shahid Beheshti University & University of Tehran.
Papers
More filters
Journal ArticleDOI
Association of polymorphisms in complement component 3 with age-related macular degeneration in an Iranian population.
Mortaza Bonyadi,Tahereh Mohammadian,Mohammad Hossein Jabbarpoor Bonyadi,Nikou Fotouhi,Masoud Soheilian,Alireza Javadzadeh,Hamid-Reza Moein,Mehdi Yaseri +7 more
TL;DR: In this article, the authors evaluated the association of C3-rs2230199 (R102G) variants with advanced type AMD in a case-control study, 494 participants consisting of 266 AMD patients (187 wet AMD and 79 advanced dry AMD).
Journal ArticleDOI
Oral colchicine for prevention of proliferative vitreoretinopathy: a randomized clinical trial.
Hamid Ahmadieh,Ramin Nourinia,Alireza Ragati Haghi,Alireza Ramezani,Morteza Entezari,Ghasem Rahmani,Mehdi Yaseri,Mehdi Yaseri +7 more
TL;DR: In this article, the first study on AS and CAT D activities in PEX patients was performed and the results indicated the role of inflammation in this group of patients, which may shed light on the complex metabolic contribution and molecular pathway of the disease.
Journal ArticleDOI
Comparison of Loteprednol with Fluorometholone after Myopic Photorefractive Keratectomy.
Farid Karimian,Amir Faramarzi,Sahba Fekri,Hossein Mohammad-Rabie,Danial Najdi,Azadeh Doozandeh,Siamak Delfaza-Baher,Mehdi Yaseri +7 more
TL;DR: The efficacy and side effects of loteprednol 0.5% and fluorometholone 0.1% after myopic PRK are comparable, and there was neither visually significant corneal haze nor ocular hypertension in any group.
Journal ArticleDOI
Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial
Mohammad Riazi-Esfahani,Hamid Riazi-Esfahani,Aliasghar Ahmadraji,Reza Karkhaneh,Alireza Mahmoudi,Ramak Roohipoor,Fariba Ghasemi,Mehdi Yaseri +7 more
TL;DR: Eyes treated with IVB plus 1 mg IVT injections had more significant reduction in CMT in early post-injection, but this effect was transient, and after 24 weeks visual acuity improvement was better in IVB group, combination therapy may decrease the number of injections.
Journal ArticleDOI
Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial
Zahra Namkhah,Fatemeh Naeini,Seyed Mahdi Rezayat,Mehdi Yaseri,Siavash Mansouri,Mohammad Javad Hosseinzadeh-Attar +5 more
TL;DR: In this paper, the effects of naringenin supplementation on lipid profile, aminotransferase levels, severity of steatosis, as well as probability of fibrosis in overweight/obese patients with NAFLD were assessed.